Results 11 to 20 of about 48,929 (237)

Coronary In-Stent Restenosis: JACC State-of-the-Art Review.

open access: yesJournal of the American College of Cardiology, 2022
The introduction and subsequent iterations of drug-eluting stent technologies have substantially improved the efficacy and safety of percutaneous coronary interventions.
G. Giustino   +7 more
semanticscholar   +1 more source

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways

open access: yesEuropean Heart Journal Open, 2023
Percutaneous coronary intervention (PCI) has evolved significantly over the past four decades. Since its inception, in-stent restenosis (ISR)—the progressive reduction in vessel lumen diameter after PCI—has emerged as the main complication of the ...
F. Pelliccia   +6 more
semanticscholar   +1 more source

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
: Advances in stent technology and the design of endovascular devices with thinner struts, anti‐inflammatory and antithrombotic polymers, and better drug kinetics have enhanced the safety and efficacy of the second‐generation drug‐eluting stents and ...
E. Erdoğan   +5 more
semanticscholar   +1 more source

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis

open access: yesFrontiers in Neurology, 2023
Background In-stent restenosis (ISR) is an adverse and notable event in the treatment of intracranial atherosclerotic stenosis (ICAS) with percutaneous transluminal angioplasty and stenting (PTAS).
Ning Wang   +7 more
semanticscholar   +1 more source

Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study

open access: yesFrontiers in Dental Medicine, 2021
Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue   +6 more
doaj   +1 more source

Hypersensitivity and in-stent restenosis in coronary stent materials

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective method for treating CHD.
Wansong Hu, Jun Jiang
semanticscholar   +1 more source

Predictors of In-Stent Restenosis [PDF]

open access: yesAngiology, 2018
Abstract Not ...
Mehmet Kadri Akboga, Samet Yilmaz
openaire   +4 more sources

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease

open access: yesFrontiers in Cardiovascular Medicine, 2023
Objective To analyze the risk factors of in-stent restenosis (ISR) after the first implantation of drug-eluting stent (DES) patients with coronary heart disease (CHD) and to establish a nomogram model to predict the risk of ISR.
Hong Xi   +6 more
semanticscholar   +1 more source

Cerebral collateral circulation as an independent predictor for in-stent restenosis after carotid artery stenting

open access: yesQuantitative Imaging in Medicine and Surgery, 2023
Background In-stent restenosis is a crucial problem after carotid artery stenting, but the exact predictors of in-stent restenosis remain unclear. We aimed to evaluate the effect of cerebral collateral circulation on in-stent restenosis after carotid ...
Luji Liu   +14 more
semanticscholar   +1 more source

Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis

open access: yesEuropean Journal of Medical Research, 2023
Purpose To investigate the safety and efficacy of Enterprise stent angioplasty and risk factors for the prognoses in treating symptomatic severe posterior circulation atherosclerotic stenosis (SSPCAS).
Zhi-Long Zhou   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy